ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 56410 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 56410; 2) Community: the network communities that were significantly associated with the response to NSC 56410; 3) Molecule: the relationships between components within communities and NSC 56410; 4) MDR: the compounds that were significantly associated with the NSC 56410.

NSC Compound Enrichment Correlation
NSC 644960 Null 0.0112651116880208 0.60921423
NSC 653860 Null 0.0112651116880208 0.56479681
NSC 658247 Pyridine-3,5-dicarboxylic acid, 1,4-dihydro-2,6-dimethyl-, bis[2-(2-hydroxybenzoyl)hydrazide] 0.0112651116880208 0.22787434
NSC 659948 7-O-(2,3,6-Trideoxy-2-fluoro-.alpha.-L-talo-hexopyranosyl)-4-demethoxydaunomycinone 0.0112651116880208 0.65550381
NSC 659950 7-O-(3,4-Di-O-acetyl-2,3,6-trideoxy-2-fluoro-.alpha.-L-talo-hexopyranosyl)-4-demethoxydaunomycinone 0.0112651116880208 0.65078599
NSC 671009 2H-Thieno[3',4':4,5]cyclopent[1,2-d]oxazole- 2,7(7aH)-dione,4,6-dibromo-3,3a-dihydro- 0.0112651116880208 0.015435139
NSC 672073 Null 0.0112651116880208 0.024336056
NSC 681639 Camptothecin Derivative 0.0112651116880208 0.66312891
NSC 682840 Butanimidoyl chloride, N-[[[[4-(trifluoromethoxy)phenyl] amino]carbonyl]oxy]- 0.0112651116880208 -0.0065101758
NSC 699499 Null 0.0112651116880208 0.026949103
Total:79  Current:20    [First] [Prev] [Next] [Last]